{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T23:53:16Z","timestamp":1768780396488,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.oooo.2013.02.022","type":"journal-article","created":{"date-parts":[[2013,5,3]],"date-time":"2013-05-03T09:07:53Z","timestamp":1367572073000},"page":"e110-e116","source":"Crossref","is-referenced-by-count":23,"title":["Oral ulcers in patients with advanced breast cancer receiving everolimus: a case series report on clinical presentation and management"],"prefix":"10.1016","volume":"116","author":[{"given":"Ourania","family":"Nicolatou-Galitis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adamantia","family":"Nikolaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilias","family":"Athanassiadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erofili","family":"Papadopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Sonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oooo.2013.02.022_bib1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ja.2010.71","article-title":"Biosynthesis of rapamycin and its regulation: past achievements and recent progress","volume":"63","author":"Park","year":"2010","journal-title":"J\u00a0Antibiot"},{"key":"10.1016\/j.oooo.2013.02.022_bib2","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1600-6143.2006.01678.x","article-title":"Clobetasol ameliorates aphthous ulceration in renal transplant patients on sirolimus","volume":"7","author":"Chuang","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.oooo.2013.02.022_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-0012.2010.01232.x","article-title":"mTOR inhibitor-associated dermatologic and mucosal problems","volume":"24","author":"Campistol","year":"2010","journal-title":"Clin Transplant"},{"key":"10.1016\/j.oooo.2013.02.022_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-4632.2009.04319.x","article-title":"Severe aphthous stomatitis associated with oral calcineurin and mTOR inhibitors","volume":"49","author":"Habib","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.oooo.2013.02.022_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/00015458.2010.11680629","article-title":"Severe stomatitis complicating immune-suppressive switch after cardiac transplantation","volume":"110","author":"Vermuelen","year":"2010","journal-title":"Acta Chir Belg"},{"key":"10.1016\/j.oooo.2013.02.022_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1756-8722-2-45","article-title":"Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy","volume":"2","author":"Yuan","year":"2009","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.oooo.2013.02.022_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11523-009-0107-z","article-title":"The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents","volume":"4","author":"Sankhala","year":"2009","journal-title":"Targ Oncol"},{"key":"10.1016\/j.oooo.2013.02.022_bib8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1586\/era.09.27","article-title":"Everolimus (RAD001): an mTOR inhibitor for the treatment of metastatic renal cell carcinoma","volume":"9","author":"Oudard","year":"2009","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.oooo.2013.02.022_bib9","unstructured":"Novartis. Afinitor; (everolimus) [prescribing information]. Available at: http:\/\/www.pharma.us.novartis.com\/product\/pi\/pdf\/afinitor.pdf. Accessed April, 2012."},{"key":"10.1016\/j.oooo.2013.02.022_bib10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/j.1875-9114.2012.01084.x","article-title":"Everolimus: targeted therapy on the horizon for the treatment of breast cancer","volume":"32","author":"Barnett","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.oooo.2013.02.022_bib11","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1109653","article-title":"Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer","volume":"366","author":"Baselga","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oooo.2013.02.022_bib12","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2217\/fon.12.49","article-title":"The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer","volume":"8","author":"Beaver","year":"2012","journal-title":"Future Oncol"},{"key":"10.1016\/j.oooo.2013.02.022_bib13","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.ejca.2011.03.017","article-title":"Natural history, management and pharmacokinetics of everolimus-induced-oral ulcers: insights into compliance issues","volume":"47","author":"Ferte","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.oooo.2013.02.022_bib14","unstructured":"Pfizer. Torisel; (temsirolimus) [prescribing information]. Available at: http:\/\/www.pfizerpro.com\/content\/showlabeling.asp. Accessed September 2, 2011."},{"key":"10.1016\/j.oooo.2013.02.022_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/cncr.24696","article-title":"Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients","volume":"116","author":"Sonis","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.oooo.2013.02.022_bib16","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.oraloncology.2011.08.009","article-title":"Clinical presentation and management of mTOR inhibitor-associated stomatitis","volume":"47","author":"De Oliveira","year":"2011","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oooo.2013.02.022_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1634\/theoncologist.2011-0111","article-title":"Oral adverse events associated with tyrosine kinase and mammalian target of rapamycin inhibitors in renal cell carcinoma: a structured literature review","volume":"17","author":"Boers-Does","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.oooo.2013.02.022_bib18","first-page":"1202","article-title":"Recurrent aphthous ulcers: a review of diagnosis and treatment","volume":"127","author":"Woo","year":"1996","journal-title":"JADA"},{"key":"10.1016\/j.oooo.2013.02.022_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1529-8019.2010.01324.x","article-title":"Aphthous ulcers","volume":"23","author":"Messadi","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.oooo.2013.02.022_bib20","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1188\/11.CJON.E83-E89","article-title":"Managing stomatitis in patients treated with mammalian target of rapamycin inhibitors","volume":"15","author":"Pillote","year":"2011","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.oooo.2013.02.022_bib21","unstructured":"Common Terminology Criteria for Adverse Events v3.0 (CTCAE), Version 3.0. Bethesda, MD: Cancer Therapy Evaluation Program, August 9, 2006 (http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/ctcaev3.pdf)."},{"key":"10.1016\/j.oooo.2013.02.022_bib22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.oooo.2013.02.022_bib23","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1634\/theoncologist.2009-0178","article-title":"FDA approval summary: temsirolimus as treatment for advanced renal cell carcinoma","volume":"15","author":"Kwitkowski","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.oooo.2013.02.022_bib24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejca.2011.11.028","article-title":"The risk of skin rash and stomatitis with the mammalian target of rapamycin inhibitor temsirolimus: a systematic review of the literature and meta-analysis","volume":"48","author":"Gomez-Fernadez","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.oooo.2013.02.022_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000329902","article-title":"Cutaneous and mucosal aphthosis during temsirolimus therapy for advanced renal cell carcinoma: review of cutaneous and mucosal side effects of mTOR inhibitors","volume":"223","author":"De Masson","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.oooo.2013.02.022_bib26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00520-005-0006-5","article-title":"Herpes simplex virus-1 (HSV-1) infection in radiation-induced oral mucositis","volume":"14","author":"Nicolatou-Galitis","year":"2006","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.oooo.2013.02.022_bib27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.oraloncology.2011.03.028","article-title":"Oral complications of targeted cancer therapies: a narrative literature review","volume":"47","author":"Watters","year":"2011","journal-title":"Oral Oncol"},{"key":"10.1016\/j.oooo.2013.02.022_bib28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1034\/j.1600-0714.2001.030008471.x","article-title":"Oral pseudomebranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash","volume":"30","author":"Nicolatou-Galitis","year":"2001","journal-title":"J\u00a0Oral Pathol Med"},{"issue":"suppl 9","key":"10.1016\/j.oooo.2013.02.022_bib29","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.20162","article-title":"Perspectives on cancer therapy-induced mucosal injury. Pathogenesis, measurement, epidemiology, and consequences for patients","volume":"100","author":"Sonis","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.oooo.2013.02.022_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2174\/1874079001104010007","article-title":"Oral mucositis, pain and xerostomia in 135 head and neck cancer patients receiving radiotherapy with or without chemotherapy","volume":"4","author":"Nicolatou-Galitis","year":"2011","journal-title":"TOCJ"},{"key":"10.1016\/j.oooo.2013.02.022_bib31","unstructured":"Oral complications of chemotherapy and head\/neck radiation (PDQ). National Cancer Institute; http:\/\/cancer.gov\/cancertopics\/pdq\/supportivecare\/oralcomplications\/HealthProfessionalVersion. Last modified April 2, 2012. Page 15."}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440313001156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440313001156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T02:47:13Z","timestamp":1715309233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440313001156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S2212440313001156"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2013.02.022","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}